Top Venture Capital Firms in France
France has emerged as one of Europe's most active venture capital markets, with VC investment reaching €8.5 billion in 2022, up from €2.8 billion in 2016. Paris in particular now rivals London and Berlin for early-stage tech funding, backed by deep engineering talent, strong government co-investment programs, and a growing base of institutional LPs committing to domestic VC managers. The directory above lists every VC firm in PEL's database for France, filterable by stage, sector, check size, and region.
The firms profiled below span that market: seed accelerators writing five-figure checks, fund-of-funds managing billions for institutional clients, sector-agnostic generalists, and firms that invest in just one vertical. The goal here is context the table can't give you: what actually distinguishes one firm from another, which structures suit which founders, and where each sits in the broader French VC ecosystem.
1. 360 Capital Partners
Founded in 1997, 360 Capital Partners predates most of the French venture ecosystem as it exists today, and its longevity shows in the breadth of its portfolio. The firm manages over €700 million in AUM across an active portfolio of more than 70 companies, and it has recently launched a dedicated deeptech technology transfer fund targeting €100 million, focused specifically on startups spun out of universities and research centres.
The firm's investment scope runs from pre-seed through Series B, with a typical check size of €5 to €15 million. That range, combined with its dual presence in Paris and Milan, makes it one of the few French-headquartered VC firms genuinely positioned to lead rounds across southern Europe rather than treat non-French deals as exceptions.
Sector priorities are deeptech, climate tech, and European research-driven startups, which aligns closely with France's own strategic emphasis on deep science commercialization through initiatives like the Sociétés d'Accélération du Transfert de Technologie network.
For founders building in hard science or climate infrastructure who need a lead investor with the track record and check size to anchor a Series A or B, 360 Capital is one of the more credible names in the Paris market.
2. Aglae Ventures
The numbers at Aglae Ventures are unusual for a Paris-based firm: $2.31 billion in AUM, a portfolio of over 100 companies, and a stated investment range of €100,000 to €100 million per deal across all stages. That last point is the defining structural fact about the firm. Very few European VCs maintain genuine flexibility across that entire spectrum, and most firms that claim stage-agnosticism in practice concentrate heavily at one end.
Aglae has a stated preference for asset-light business models, including marketplaces and platform businesses. That focus, combined with the breadth of its check-size range, suggests a firm that is comfortable both incubating early ideas and following on aggressively into later rounds for companies already in its portfolio.
3. Altamir
Altamir is structurally different from every other firm on this page. It is a listed private equity company traded on Euronext Paris under the ticker LTA, which means its investment activity is visible in ways that a traditional closed-end fund is not. With €1.5 billion in AUM, a current portfolio of 17 companies, and a recorded total of 506 investments, Altamir operates at a scale and with a public accountability that separates it from the typical GP-LP fund structure.
Founded in 1995, it is also one of the oldest vehicles in the French private assets market. The concentrated current portfolio of 17 holdings relative to that total investment count suggests a firm that actively manages positions and recycles capital rather than accumulating passive minority stakes. For institutional investors or founders considering a firm's staying power and exit discipline, the listed structure provides a degree of transparency that private fund disclosures rarely match.
4. A Plus Finance
A Plus Finance has been operating since 1998 and has grown to approximately €1 billion in AUM as of the end of 2023. Its historical average check size of $15.4 million places it firmly in the growth and mid-stage bracket, and the 2012 vintage of its Fund I, described as a seed venture capital fund, suggests the firm has been actively building a seed-to-growth continuum over time rather than sitting fixed at one stage.
Paris-headquartered and with a long institutional history, A Plus Finance is the kind of firm that tends to suit founders who want a partner with deep French market relationships and the balance sheet to participate across multiple funding rounds.
5. Access Capital Partners
Access Capital Partners is not a direct VC investor in the conventional sense. It is a fund-of-funds manager with €15.1 billion in total AUM, investing in European private assets on behalf of institutional investors and private clients. Its most recent fund closed at €400 million in November 2022. Founded in 1998 and independently owned, the firm employs between 51 and 200 people, which is substantial for a Paris-based alternatives manager.
Its relevance here is for institutional allocators rather than founders. If you are an LP building exposure to European venture and private equity through a managed allocation vehicle rather than committing to individual fund managers, Access Capital is one of the larger and more established options domiciled in France.
6. Advent France Biotechnology
Advent France Biotechnology is one of the few French VC firms operating with a genuinely narrow, thesis-driven mandate: early-stage life sciences and biotechnology, invested primarily across France, Belgium, Spain, and Ireland. Founded in 2016, the firm launched its first fund in 2017 and deployed that capital into 15 European companies before bringing its second fund to a first close at €86 million.
The typical check size of $1 to $5 million reflects a seed and early Series A focus, and the geographic scope across four countries gives the firm visibility into European biotech deal flow that Paris-only managers rarely see. For life sciences founders in particular, the sectoral specificity matters: Advent's team is calibrated for scientific due diligence in a way that a generalist tech VC is not.
7. 4D Global Energy Advisors
4D Global Energy Advisors occupies a niche that few Paris-based firms touch: institutional asset management focused exclusively on the global energy and hydrocarbon sector. Founded in 2002, its debut fund closed at $81 million, with Société Générale Asset Management providing a $25 million anchor commitment. A second vehicle, 4D Global Energy Investments, closed in July 2010 at $216 million in commitments.
The 2007-vintage 4D Global Energy Development Capital Fund II is an oil and gas fund, which is a sector orientation that has become considerably more complex to market to institutional LPs since then. For anyone building in conventional energy or hydrocarbon infrastructure and looking for a specialist investor with an established track record in that vertical, 4D is one of the few French managers with that specific history. It is a narrow fit, but for the right company, that specificity is the point.
8. Alliance Entreprendre
One of the older names in French venture capital, Alliance Entreprendre was founded in 1995 and had built over €515 million in assets before being acquired in April 2022. The firm has recorded at least 31 investments and 8 exits, with a focus on early-stage venture. With 11 to 50 employees, it operated at a relatively lean scale relative to its asset base.
The 2022 acquisition changes the practical question for any founder or LP approaching the firm today. Without more detail on the acquiring entity and any resulting changes to investment mandate or team composition, Alliance Entreprendre is worth researching carefully through its current principals before drawing conclusions from its pre-2022 track record.
9. Aloe Private Equity SAS
Aloe Private Equity has been investing from its Paris base since 2003, with $211 million in AUM and a typical deal size of $10 to $50 million. That check range sits above what most seed-stage founders are looking for, but it makes Aloe a natural fit for growth-stage rounds in its core sectors: energy, renewables, retail, technology, and impact-driven businesses including fintech.
The combination of a renewable energy focus and an impact investment orientation is not uncommon in European private equity, but Aloe has held that positioning for long enough that it predates the recent surge of capital into ESG-labeled strategies. For founders in climate tech or fintech seeking a growth-stage investor with a longer institutional history in responsible investing than most, the track record here is more substantive than the marketing language around impact investing often implies.
10. 50 Partners
50 Partners is the most tightly structured investor on this list. Founded in 2012 as a Paris-based startup accelerator and VC firm, it writes checks between $20,000 and $500,000, and its investment policy is categorical: it only invests in companies it has itself accelerated. That condition is not a preference or a soft priority; it is the operating rule.
For very early-stage founders, the practical implication is that accessing 50 Partners' capital requires going through its acceleration program first. That can be a significant commitment, but for founders at the idea or pre-product stage who benefit from structured mentorship alongside capital, the model has a logic to it that pure check-writing VCs do not replicate.
Let’s Recap
The firms above cover almost every structural variation in the French VC market. At one end, 50 Partners and Advent France Biotechnology have the narrowest mandates, the former restricted by programme participation, the latter by sector and geography. At the other end, Aglae Ventures and Altamir deploy across a wide range of stages and ticket sizes, with Altamir's listed structure adding a layer of public accountability closed-end funds don't offer.
Stage matters enormously here. 360 Capital Partners and Advent France Biotechnology both sit at the early end but serve very different founders: 360 targets deeptech and university spinouts across southern Europe, while Advent is scientific and life-sciences specific. A Plus Finance and Aloe Private Equity write larger checks, better suited to founders already raising growth capital. Access Capital Partners sits outside the founder-investor relationship entirely; as a fund-of-funds, it's relevant to institutional allocators, not startups.
By sector, the clearest lines are biotech and life sciences (Advent France Biotechnology), energy and impact (Aloe Private Equity), oil, gas, and conventional energy infrastructure (4D Global Energy Advisors), and broad deeptech and climate (360 Capital Partners). Aglae's marketplace and asset-light focus sets it apart from all of them. If your company doesn't map cleanly to one sector, the generalist platforms, 360 Capital, Aglae, and A Plus Finance, are the more pragmatic starting points.
Check size is the most direct filter:
- Pre-product or very early: 50 Partners ($20,000–$500,000), Advent France Biotechnology ($1–5 million)
- Series A/B: 360 Capital Partners (€5–15 million), A Plus Finance (historical average of $15.4 million)
- Growth equity: Aloe Private Equity ($10–50 million), a bracket most of the others don't reach